We can't rule out double-digit retail sales growth in the final quarter.

Our increased level of investment in marketing and sales, with the priority on key growth drivers, resulted in a sales growth of 21 percent in Pharmaceuticals in the U.S.,

We expect export growth to moderate in coming months but not too much as trade flows from China will remain healthy and the U.S. economy is performing quite well.

We are confident of delivering in 2006 another year of dynamic growth with record sales and earnings.

We have now registered our fourth consecutive quarter of strong sales growth and our third consecutive quarter of higher earnings, excluding special items,

We're very encouraged by the growth in digital sales. And while international sales still has a ways to go, there is a lot of upside.